During the last decade of years, remarkable technological innovations have emerged that allow the direct or indirect determination of transcriptome at unprecedented scale and speed. Studies using these methods have already altered our view of the extent and complexity of transcript profiling, which has advanced from one-gene-at-a-time to a holistic view of the genome. Here, we outline the major technical advances in transcriptome characterization, including the most popular used hybridization-based platform, the well accepted tag-based sequencing platform, and the recently developed RNA-Seq (RNA sequencing) based platform. Especially, the nextgeneration technologies make a revolution in assessing the entire transcriptome via 1
the recent RNA-Seq technology.
Introduction
Transcriptome is defined as the set of all messenger RNA (mRNA) molecules, or transcripts, produced in one or a population of cells at a certain time. The term can also be applied to the specific subset of transcripts present in a particular cell type. It offers a more holistic approach to interpret the functional elements of the genome and therefore builds a foundation for the global understanding of biological processes.
Various high-throughput systems have been developed to deduce and quantify transcriptome. These methods can be divided into three classes: (1) Hybridizationbased platform, typically involving fluorescently labeled cDNA microarrays or commercial high-density oligo microarrays; (2) Tag-based sequencing platform, including SAGE or MPSS; (3) RNA-Seq based transcriptome platform. Currently, each of these methods has inherent advantages and disadvantages, often related to expense, technical difficulty, specificity, and reliability (Table 1 ). The appropriate method should be chosen to fit the objectives in each experiment. However, recent studies implicated that RNA-Seq approach has clear advantages over existing approaches and is opening a new vista in revolutionizing the manner in which transcriptome is analyzed (Blow 2009; Mortazavi et al. 2008; Wang et al. 2009 ).
Hybridization-based transcriptome platform
Microarrays, or gene chips, which allow the simultaneous monitoring of the expression of thousands of genes, have become the most popular platform among (Southern 1975) .
Then, researchers began to work on a reciprocal technique, in which the known genes or fragments were immobilized on a substrate, and the solution to be queried was labeled and hybridized to the surface (Bains and Smith 1988; Drmanac et al. 1989 ).
The first use of microarray as a global approach to create a transcript profiling was reported in 1995 (Schena et al. 1995) , with some 1000 cDNAs printed on a glass slide. In 1997, a complete genome (Saccharomyces cerevisiae) on a microarray was published (DeRisi et al. 1997; Lashkari et al. 1997 ).
The essence of microarray is the parallel hybridization of complementary nucleic acid strands (Fig. 1) . The specific targets (the labeled nucleic acid from a given cell) could be simultaneously hybridized with the thousands of probes (DNA fragments of a gene) immobilized on a solid surface (nylon membranes, glass slides, etc). The signal intensity of the hybridized probe is proportional to the gene expression level and hence it serves as an estimate of the expression level of each specific gene. According to the nature of the probe, there are two main types of DNA microarrays: cDNA microarray (Schena et al. 1995) and oligonucleotide microarray (Lockhart et al. 1996) . Probes for cDNA microarrays are usually obtained from genomic clones or polymerase chain reaction (PCR) amplification, and then these sequences are spotted using an automated microarray spotter. Probes for oligonucleotide microarrays are Since it appears, microarray has produced a vast amount of data. MIAME (Minimum Information about a Microarray Experiment) (Brazma et al. 2001 ) and MAQC (MicroArray Quality Control) (Shi et al. 2008; Shi et al. 2006) projects have been created to advance the field of transcriptome by establishing and assessing standard guidelines for comparison of these data. Now, Microarray derived data must adhere to MIAME standards and should be deposited in a public repository such as Gene Expression Omnibus (GEO) (Edgar et al. 2002 ), ArrayExpress Database (Brazma et al. 2003 , and Stanford Microarray Database (Ball et al. 2005) . The tools to analyze microarray data are also widely available and developed, making analysis less complicated and easier. Indeed, microarray has been a reliable and stable technology, which is well accepted by scientists. Now, one main trend in DNA microarray development is high-density of microarray (tiling arrays) that more than 1 million probes can be mounted onto every square cm by in situ synthesis. This could provide massively parallel approaches for the characterization of all expressed exons. However, any unexpected sequences will still be missed. Minimization of reaction system is another trend in DNA microarray development, as sometimes large amounts of material can be difficult to be obtained.
The decreasing minimum starting requirement of input RNA or DNA would make it possible to study the expression profile of even a single cell. results in several inherent limitations. There may be potentially confounding effects of cross-hybridization among highly related sequences. The sensitivity of microarrays is still low despite of the improvements in signal detection (Stears et al. 2000) . In addition, the method is actually semi-quantitive, as the method can detect only twofold or greater changes, with bad technical reproducibility in slight changes of gene expression. The number of DNA probes that fit on a microarray is limited, putting constraints on the provided information. Moreover, comparing expression levels across different experiments is often difficult and it requires complicated normalization methods.
Tag-based sequencing transcriptome platform
In parallel to the remarkable advances in hybridization based techniques, tag-based sequencing technologies for measuring absolute abundance of gene expression have made significant advances. Large-scale quantitative expression technologies involve the collection and sequencing of short sequence tags from a given RNA sample, and use the abundance of these sequence tags to determine the abundance of each transcript. As an open system, the methods are complementary to standard microarrays, and they can be utilized to discover novel transcripts expressed in a cell. Serial analysis of gene expression (SAGE) is a method that could both qualitatively and quantitatively evaluate the expression of thousands of genes simultaneously by sequencing the tagged cDNA fragments (Velculescu et al. 1995) . As an improvement of traditional EST sequencing (Adams et al. 1991) , which is the first sequencingbased method to detect gene expression, SAGE provides a highly reliable identification of gene expression at a much less cost than EST sequencing by minimizing the amount of information collected per transcript.
The procedure of SAGE involves several steps ( Fig. 1) , including total RNA isolation, mRNA purification, cDNA synthesis, tags generation by enzyme digestion, concatenation, amplification and sequencing of tags, and it only rests on two principles: First, a short nucleotide sequence tag of 10-14 bp, released from the cDNA by a specific Type IIS restriction enzyme (tagging enzyme) (e.g. NlaIII and BsmFI) digestion, contains enough information to uniquely identify a transcript (Pennisi 2000); Second, these tags could be serially connected to form a long stretch of DNA molecule, and sequencing reaction would be needed only once. The frequency of detection of each tag represents the quantification and identification of the transcripts detected. Now SAGE is a popular used method to characterize transcripts profiles because it can be performed in individual labs and it has generated data sets that have proven valuable for the annotation of complex genomes (Saha et al. 2002; Wang 2007) . The conventional SAGE has been further optimized. LongSAGE (Saha et al. 2002) , CAGE (Shiraki et al. 2003) and SuperSAGE (Matsumura et al. 2003) were developed by using different tagging enzymes to release longer tags, which would provide higher specificity for transcript identification. Recently, a so-called SuperSAGE array was At present, a few disadvantages remain with the technique (Table 1) . Due to the relatively short sequences generated, a major limitation of SAGE is that the accuracy of the gene origin determined for some SAGE tags cannot be guaranteed. This will influence the understanding of the dynamic transcripts processes (Pleasance et al. 2003; Wang 2007) . In addition, although the generation of sequence tags is without prior knowledge of nucleotide and ideal for the discovery of novel transcripts, a reference genome to determine gene identity is needed. The SAGE process involves enzyme digestions, PCR amplifications, cloning and colony propagations, which could result in a quantitative bias for different tags (Margulies et al. 2001; Siddiqui et al. 2006) . Furthermore, the rare mRNAs also exceed the detection region of SAGE due to its limited sequencing capability (Wang 2007).
Massively parallel signature sequencing, MPSS
Developed at what is now Illumina, Inc. (originally Lynx Therapeutics, Hayward,CA), MPSS is another tag-based methodology that has been used for deep transcriptome analysis and genome annotation (Brenner et al. 2000) . MPSS has similar advantages and disadvantages to SAGE. However, the unique feature of MPSS is the bead-based sequencing technology, which generates longer and more tags that make gene identification more accurate, sensitive, and fast. Hence, MPSS potentially provides a greater and more accurate coverage of transcriptome than SAGE.
MPSS is based on the in vitro cloning of millions of cDNA fragments and (Fig. 1) . First, cDNA is synthesized followed by digestion with the tagging enzyme DpnII, thus leaving a signature or tag sequence. These fragments are cloned into a special plasmid carrying the random 32-bp adapter (barcode), followed by PCR amplification. The amplification products are then linked to the corresponding microbeads by adapter hybridization, followed by high throughput sequencing in a flow cell. The procedure is completely parallel, 
RNA-Seq based transcriptome platform
As a newer and more comprehensive platform to map transcriptome, RNA-Seq (RNA-Sequencing) approach is developed by direct ultra high-throughput sequencing of cDNAs using one of the NGS (next-generation sequencing) methods (Table 2) (Fig. 1) . Then the cDNA library is randomly sheared. The resulting individual DNA fragments, with or without amplification, are sequenced by massively parallel sequencing methods. Subsequently, the resulting sequence reads are individually mapped to the source genome, or assembled de novo without the genomic sequence to produce a genome-scale transcription map.
Alternatively, another application of RNA-Seq approach focuses on capturing the information-rich 3'-untranslated region (UTR) of messenger RNAs (mRNAs) (Eveland et al. 2008) , and it is not designed to discriminate different splice variants or to detect mutations within the expressed exons.
In theory, any NGS technology (Table 2) can be used for RNA-Seq method, and Illumina's Genome Analyzer, Roche's 454 sequencer and Applied Biosystems' SOLiD System have already used for this purpose. The recent commercial availability of Helicos Biosciences tSMS system, which has not yet been used for published RNASeq studies, is also appropriate and offers the additional advantage of avoiding the requirement for amplification of target cDNA. In the case of transcriptome sequencing, more informative read length is always an advantage (Torres et al. 2008) and the read length is determined by the adopted NGS technology. Longer read length (>200 bp) could be achieved with 454-based platform, initially described by (Table 2) .
RNA-Seq method has clear advantages over existing approaches (Table 1) . First, the longer signatures of RNA-Seq method can be unambiguously mapped to unique transcripts of the genome. Second, the method allows evaluating global splicing patterns, detecting novel expressed exons and identifying transcript sequence polymorphisms in a given sample. Third, the reproducibility of the approach has been shown to be extremely high for both technical and biological replicates. Thus, the presence and amount of each transcript can be compared with that in any other sequenced sample, now or in the future. Finally, RNA-Seq method requires less RNA sample and avoids the bias formed in the cloning steps. There is even no need for amplification step armed with the single molecule sequencing (e.g. Helicos Biosciences tSMS system). Moreover, RNA-Seq can provide information on transcripts that are expressed at very low levels, limited only by the total number of reads that are generated.
RNA-Seq method has demonstrated its enormous potential for transcriptome studying in life science. Several recent papers described the application of RNA-Seq method to acquire the transcriptomes of mammals (Cloonan et al. 2008; Mortazavi et al. 2008; Sultan et al. 2008 ), yeast (Nagalakshmi et al. 2008 Yassour et al. 2009) Nevertheless, RNA-Seq method also has its weaknesses (Table 1) 
Summary and perspectives
The hybridization-based transcriptome platform has been the method of choice for transcriptome profiling for more than a decade, with a lower workload and a relatively lower cost. The platform suffers from limitations such as background noise and cross hybridization. In addition, this technology can only provide information about the transcripts that are included on the array. Therefore, it would be obsolete for determining transcriptome in the future.
The tag-based transcriptome platform (SAGE or MPSS) has provided key information Although RNA-Seq method is still in its infancy, it has clear advantages over previously developed transcriptome platforms. With the trend of declining sequencing costs, more researchers would prefer RNA-Seq method because of the added power and quality that involve determining the structure and dynamics of transcripts.
Simultaneously, it should be noted that it is a long way to go before RNA-Seq method reaches the level of adoption that microarrays have. 
